drozitumab: Clinical Trials

5 trials of drozitumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1
Phase 12Completed 2

Follow drozitumab: new trials by email Literature Review of drozitumab trials Research Report on drozitumab

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)
bevacizumab, FOLFOX, PRO95780 - Metastatic Colorectal Cancer
Phase 1CompletedGenentech, Inc.92009-05-012022-12-13
A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)
PRO95780, rituximab - Non-Hodgkin's Lymphoma
Phase 2CompletedGenentech, Inc.492008-03-012017-06-06
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)
bevacizumab, cetuximab, FOLFIRI regimen - Colorectal Cancer
Phase 1CompletedGenentech, Inc.202007-10-012017-05-19
A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)
bevacizumab, carboplatin, paclitaxel - Non-Small Cell Lung Cancer
Phase 2CompletedGenentech, Inc.1282007-06-012017-05-18
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
PRO95780 - Chondrosarcoma
Phase 2TerminatedGenentech, Inc.152007-05-312022-12-13

Conditions studied

Colonic Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Chondrosarcoma (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Sarcoma (1)  ·  Sarcoma, Synovial (1)

Sponsors

Genentech, Inc. (5)

Countries

Australia (1)  ·  United States (1)

Top investigators

Gordon Bray, M.D. (3)  ·  Chia Portera, M.D. (1)  ·  Sandra Skettino, M.D. (1)